Concepedia

Publication | Open Access

Olverembatinib After Failure of Tyrosine Kinase Inhibitors, Including Ponatinib or Asciminib

DOIFull Paper Access

21

Citations

14

References

2024

Year

Elias Jabbour, Vivian G. Oehler, Paul Koller, Omer Jamy, Elza Lomaia, Anthony M. Hunter, Olga Uspenskaya, Svetlana Samarina, Sudipto Mukherjee, Jörge E. Cortes,
JAMA Oncology

Abstract

ClinicalTrials.gov Identifier: NCT04260022.

References

YearCitations

Page 1